Abstract

Methyl 2,6-dideoxy-4-O-methoxymethyl-α-L-erythro-hexopyranosid-3-ulose (1) reacted with potassium cyanide under equilibrating conditions to give methyl 3-C-cyano-2,6-dideoxy-4-O-methoxymethyl-α-L-arabino-hexopyranoside (11). The mesylate (12) derived from this cyanohydrin was converted by established procedures, although not without difficulty, into methyl 3-acetamido-2,3,6-trideoxy-4-O-methoxymethyl-3-C-methyl-α-L-ribo-hexopyranoside (17), which was then converted in a straightforward manner into methyl 3-acetamido-2,3,6-trideoxy-3-C-methyl-α-L-ribo-hexopyranoside (20). Inversion of the configuration at C-4 of the latter compound, by means of an oxidation–reduction sequence, yielded methyl 3-acetamido-2,3,6-trideoxy-3-C-methyl-α-L-xylo-hexopyranoside (22), a derivative of the novel branched-chain amino sugar found in antibiotic A35512B.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.